Lewis A. Opler
#130,363
Most Influential Person Now
Lewis A. Opler's AcademicInfluence.com Rankings
Download Badge
Biology
Lewis A. Opler's Degrees
- Doctorate Medicine Columbia University
- PhD Psychiatry Columbia University
Why Is Lewis A. Opler Influential?
(Suggest an Edit or Addition)Lewis A. Opler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The positive and negative syndrome scale (PANSS) for schizophrenia. (1987) (18374)
- Reliability and validity of the positive and negative syndrome scale for schizophrenics (1988) (964)
- The Positive and Negative Syndrome Scale (PANSS): Rationale and Standardisation (1989) (959)
- Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. (1997) (357)
- Risk factors for long-term homelessness: findings from a longitudinal study of first-time homeless single adults. (2005) (318)
- Significance of Positive and Negative Syndromes in Chronic Schizophrenia (1986) (201)
- Risk factors for homelessness among schizophrenic men: a case-control study. (1994) (182)
- Positive and Negative Syndromes in Chronic Schizophrenic Inpatients (1984) (142)
- Treatment of schizophrenia 1999 (1999) (136)
- The positive-negative dimension in schizophrenia: its validity and significance. (1987) (125)
- Risk factors for homelessness among women with schizophrenia. (1995) (118)
- Neurological signs and the positive-negative dimension in schizophrenia (1990) (117)
- Akathisia, suicidality, and fluoxetine. (1992) (110)
- Positive and negative syndromes in schizophrenia as a function of chronicity (1986) (98)
- Amantadine in the treatment of neuroendocrine side effects of neuroleptics. (1987) (83)
- A critical time intervention with mentally ill homeless men: impact on psychiatric symptoms. (2000) (81)
- Risk factors for homelessness among indigent urban adults with no history of psychotic illness: a case-control study. (2000) (81)
- The role of pimozide in clinical psychiatry: a review. (1991) (79)
- Positive and negative subtypes in acute schizophrenia. (1984) (73)
- SCID-PANSS: two-tier diagnostic system for psychotic disorders. (1991) (71)
- Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis. (1994) (64)
- Pharmacotherapy of post-traumatic stress disorder. (2006) (62)
- A single‐dose, randomized, double‐blind, placebo‐controlled trial of sublingual asenapine for acute agitation (2014) (61)
- Visual Information Processing in Positive, Mixed, and Negative Schizophrenic Syndromes (1990) (56)
- Management of schizophrenia with obsessive-compulsive features. (2009) (55)
- Dot Enumeration Perceptual Organization Task (DEPOT): evidence for a short-term visual memory deficit in schizophrenia. (1996) (54)
- Mediation by cyclic AMP of hormone-stimulated glycogenolysis in cultured rat astrocytoma cells. (1972) (53)
- Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping (1987) (53)
- Correlates of codisorders in homeless and never homeless indigent schizophrenic men (1994) (52)
- The American Psychiatric Publishing Textbook of Schizophrenia (2006) (43)
- Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia (2015) (39)
- Symptom Profiles and Homelessness in Schizophrenia (1994) (38)
- Pimozide treatment of the negative schizophrenic syndrome: an open trial. (1988) (36)
- Attention deficit disorder psychosis as a diagnostic category. (1987) (33)
- Schizophrenia with Obsessive-Compulsive Features: Assessment and Treatment (1994) (33)
- Evaluation in an inpatient setting of DTREE, a computer-assisted diagnostic assessment procedure. (1993) (31)
- Management of Schizophrenia With Obsessive-Compulsive Disorder (2000) (31)
- EEG biofeedback treatment of ADD. A viable alternative to traditional medical intervention? (2001) (31)
- L-DOPA in the Treatment of Negative Schizophrenic Symptoms: A Single-Subject Experimental Study (1986) (30)
- High-dose naloxone in tardive dyskinesia (1988) (27)
- Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish (2015) (24)
- Negative symptom rating scale: Limitations in psychometric and research methodology (1986) (20)
- Psychopharmacologic treatment of negative schizophrenic symptoms. (1994) (20)
- Long-term impact of web-based tools, leadership feedback, and policies on inpatient antipsychotic polypharmacy. (2011) (19)
- Simple schizophrenia, negative symptoms, and prefrontal hypodopaminergia. (1992) (19)
- Impact of Smoking Cessation on Psychiatric Inpatients Treated with Clozapine or Olanzapine (2010) (17)
- Pharmacologic treatment of delusions. (1995) (17)
- Comorbid: Posttraumatic stress disorder and schizophrenia (2005) (17)
- Symptom-Specific Group Therapy for Inpatients with Schizophre n i a (2001) (17)
- Pharmacotherapy of cognitive deficits in schizophrenia (2013) (17)
- The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors. (1989) (16)
- Safety Evaluation of the Concomitant Use of Clozapine and Benzodiazepines: A Retrospective, Cross-Sectional Chart Review (2008) (15)
- Psychostimulants in the Treatment of Adults with Psychosis and Attention Deficit Disorder (2001) (14)
- Negative schizophrenic symptoms are associated with backward masking vulnerability (1990) (14)
- Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events (2016) (13)
- Return of menstruation after switching from risperidone to olanzapine. (1998) (13)
- Birth seasonality and schizophrenia. (1985) (13)
- Positive and negative subtypes in schizophrenia. (1987) (12)
- Rethinking Medication Prescribing Practices in an Inner-City Hispanic Mental Health Clinic (2004) (12)
- Hematologic impact of antibiotic administration on patients taking clozapine. (2012) (12)
- Activation Symptoms and Discharge in Elderly Chronic Schizophrenic Inpatients (2004) (11)
- Impairment in emotional modulation of attention and memory in schizophrenia (2014) (11)
- Exploring the Potential Effect of Polypharmacy on the Hematologic Profiles of Clozapine Patients (2014) (11)
- Integrating psychopharmacology and cognitive remediation to treat cognitive dysfunction in the psychotic disorders (2013) (10)
- Sex differences in hedonic judgement of odors in schizophrenia cases and healthy controls (2018) (10)
- Sertraline and akathisia. (1994) (10)
- Validation of the Russian Version of the Positive and Negative Syndrome Scale (PANSS-Ru) and Normative Data. (2018) (9)
- The Evolving Brain: The Known and The Unknown (2007) (9)
- Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS) (2017) (9)
- Genetics of schizophrenia and the positive-negative dimension. (1985) (8)
- Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics. (1986) (8)
- Schizophrenia: A Multidimensional Disorder (1994) (8)
- Effects of Statins and Cholesterol on Patient Aggression: Is There a Connection? (2018) (8)
- Use of the Positive and Negative Syndrome Scale (PANSS) in Clinical Practice (1998) (7)
- The Symptoms of Trauma Scale (SOTS): Psychometric evaluation and gender differences with adults diagnosed with serious mental illness (2016) (7)
- Neurocognitive features of chronic schizophrenic inpatients. (1991) (7)
- Combined mesoridazine and amantadine treatment in refractory schizophrenics (1985) (6)
- Physician Prescribing Practices of Vitamin D in a Psychiatric Hospital. (2016) (6)
- Abnormal phospholipid metabolism in schizophrenia: evidence from epidemiological findings, clinical observations, and preliminary clinical trials. (2001) (5)
- The changing presentation of catatonia. (1987) (5)
- Reducing guesswork in schizophrenia treatment (2006) (5)
- Deficit or negative syndrome? (1989) (5)
- Multimedia Reviews: The Culture of Emotions: A Cultural Competence and Diversity Training Program (2002) (5)
- Fluoxetine and Preoccupation With Suicide (1991) (4)
- Management of Schizophrenia with: Obsessive-Disorder Compulsive (2005) (4)
- Serotonergic agents and frontal lobe syndrome. (1994) (4)
- Comorbidities in Schizophrenia: Challenges for Researchers and Clinicians (2013) (3)
- The Symptoms of Trauma Scale (SOTS): An Initial Psychometric Study (2015) (3)
- Dilapidation in schizophrenia: Relationship to negative syndrome and prefrontal impairment (1990) (3)
- FLUOXETINE AND PREOCCUPATION WITH SUICIDE. REPLY (1991) (3)
- Relationship between Neuroleptic Dose and Positive and Negative Symptoms (1994) (3)
- Transcending Psychosis: The Complexity of Comorbidity in Schizophrenia. (2016) (3)
- Zonisamide-induced psychosis in a patient with bipolar disorder and narcolepsy. (2014) (3)
- Reflections on "Emil Kraepelin: Icon and Reality". (2016) (2)
- Information processing deficit in schizophrenia: a frontal lobe sign? (1989) (2)
- Tardive dyskinesia and institutional practice: current issues and guidelines. (1980) (2)
- Cognitive deficits in affective disorders and schizophrenia. (1995) (2)
- CONCEPTUALIZING ADHD. AUTHOR'S REPLIES (1994) (2)
- Conducting clinical psychiatric research in "non-research" settings. (1994) (2)
- The possible role of dopamine autoreceptors in neuroleptic atypicality. (1988) (2)
- Alprazolam in the treatment of bulimia. (1986) (2)
- Abnormalities in the brain and schizophrenia. (1990) (1)
- This Issue: Managing Comorbidities in Schizophrenia (2005) (1)
- New Agents for Treating Negative Symptoms (1995) (1)
- Drug interaction review in a psychiatric population (2017) (1)
- Antipsychotic Drugs and Interactions: Implications for Criminal and Civil Litigation (2012) (1)
- Neuroendocrine Side Effects of Neuroleptics (1988) (1)
- Oseltamivir use in psychiatric inpatients taking clozapine: effect on neuropsychiatric events. (2011) (1)
- Pain insensitivity and affective flattening in schizophrenia (1993) (1)
- INFLUENCE OF ERGOT DERIVATIVES ON THE DIFFERENT TYPES OF DOPAMINE RECEPTORS AND ON OTHER AMINE RECEPTORS IN PRIMATE BRAIN (1979) (1)
- Imipramine and Clonazepam for Panic Disorder (1989) (1)
- FLUOXETINE-DOPAMINERGIC INTERACTION DATA. AUTHORS' REPLY (1994) (1)
- Codisorders and homelessness in schizophrenia: Gender differences (1993) (0)
- Cognitive Symptoms in Schizophrenia Recognizing and Treating Cognitive Deficits in Schizophrenia (2009) (0)
- Dear Family Members and Healthcare Providers (2007) (0)
- A POSITIVE AND NEGATIVE SYMPTOM SCALE FOR CHILDREN AND ADOLESCENTS: THE KIDDIE‐PANSS (1992) (0)
- Pimozide-induced depression? (1993) (0)
- Synopsis of neuropsychiatry (1995) (0)
- Pentoxifylline and panic attacks. (1994) (0)
- Neuroleptic effects on positive and negative phenomenology in schizophrenia (1993) (0)
- Crisis intervention services to the Lubavitch community following the Brooklyn Bridge shooting: A public-private collaboration (1999) (0)
- Rating Scales for Psychiatric Disorders (2016) (0)
- Schizophrenia and clozapine treatment. (1993) (0)
- Adjunctive Sarcosine and N-Acetylcysteine Use for Treatment-Resistant Schizophrenia (2018) (0)
- Comparative validity of alternative systems for interpretation of PANSS rated symptoms of schizophrenia (2003) (0)
- Response to letter from Khan et al. (2015) (0)
- Caton et al. Respond [2] (2006) (0)
- Beyond Principal-Component Analysis of the Positive and Negative Syndrome Scale in Patients with Schizophrenia (2002) (0)
- Conceptualizing ADHD. (1994) (0)
- Novel Antipsychotic Drugs (1993) (0)
- Clinical and Neurobiological Advances in Psychiatry, Volume 1: Advances in the Neurobiology of Schizophrenia (1996) (0)
- Re: The Combined Use of Atypical Antipsychotics and Cognitive-Behavioural Therapy in Schizophrenia (2003) (0)
- Contents of The Journal of Nervous and Mental Disease (1991) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lewis A. Opler?
Lewis A. Opler is affiliated with the following schools:
